MARKED INVIVO ANTIRETROVIRUS ACTIVITY OF 9-(2-PHOSPHONYLMETHOXY-ETHYL)ADENINE, A SELECTIVE ANTI-HUMAN IMMUNODEFICIENCY VIRUS AGENT

被引：269
作者：
BALZARINI, J
NAESENS, L
HERDEWIJN, P
ROSENBERG, I
HOLY, A
PAUWELS, R
BABA, M
JOHNS, DG
DECLERCQ, E
机构：
[1] CZECHOSLOVAK ACAD SCI, INST ORGAN CHEM & BIOCHEM, CS-16610 PRAGUE 6, CZECHOSLOVAKIA
[2] NCI, DIV CANC TREATMENT, DEV THERAPEUT PROGRAM, BETHESDA, MD 20892 USA
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1989年 / 86卷 / 01期
关键词：
D O I：
10.1073/pnas.86.1.332
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：332 / 336
页数：5
相关论文
共 28 条
[1]   THE 2',3'-DIDEOXYRIBOSIDE OF 2,6-DIAMINOPURINE SELECTIVELY INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REPLICATION INVITRO [J].
BALZARINI, J ;
PAUWELS, R ;
BABA, M ;
ROBINS, MJ ;
ZOU, R ;
HERDEWIJN, P ;
DECLERCQ, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 145 (01) :269-276
[2]   THE INVITRO AND INVIVO ANTI-RETROVIRUS ACTIVITY, AND INTRACELLULAR METABOLISM OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE AND 2',3'-DIDEOXYCYTIDINE ARE HIGHLY DEPENDENT ON THE CELL SPECIES [J].
BALZARINI, J ;
PAUWELS, R ;
BABA, M ;
HERDEWIJN, P ;
DECLERCQ, E ;
BRODER, S ;
JOHNS, DG .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) :897-903
[3]   COMPARATIVE INHIBITORY EFFECTS OF SURAMIN AND OTHER SELECTED COMPOUNDS ON THE INFECTIVITY AND REPLICATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV-III) LYMPHADENOPATHY-ASSOCIATED VIRUS (LAV) [J].
BALZARINI, J ;
MITSUYA, H ;
DECLERCQ, E ;
BRODER, S .
INTERNATIONAL JOURNAL OF CANCER, 1986, 37 (03) :451-457
[4]   ON THE SHELF AIDS DRUG IN CLINICAL-TRIAL [J].
BARNES, DM .
SCIENCE, 1987, 238 (4825) :276-276
[5]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[6]  
BRODER S, 1985, LANCET, V2, P627
[7]  
COLLINS JM, 1986, J CLIN PHARMACOL, V26, P22
[8]   RIBAVIRIN TREATMENT OF THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME-RELATED COMPLEX (ARC) - A PHASE-1 STUDY SHOWS TRANSIENT CLINICAL IMPROVEMENT ASSOCIATED WITH SUPPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS AND ENHANCED LYMPHOCYTE-PROLIFERATION [J].
CRUMPACKER, C ;
HEAGY, W ;
BUBLEY, G ;
MONROE, JE ;
FINBERG, R ;
HUSSEY, S ;
SCHNIPPER, L ;
LUCEY, D ;
LEE, TH ;
MCLANE, MF ;
ESSEX, M ;
MULDER, C .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) :664-674
[9]   A NOVEL SELECTIVE BROAD-SPECTRUM ANTI-DNA VIRUS AGENT [J].
DECLERCQ, E ;
HOLY, A ;
ROSENBERG, I ;
SAKUMA, T ;
BALZARINI, J ;
MAUDGAL, PC .
NATURE, 1986, 323 (6087) :464-467
[10]  
DECLERCQ E, 1989, IN PRESS ANTIMICROB
123